Aclarion, a company focused on spine pain diagnostics, listed a $3 million public offering, the company said Feb. 26.
The company listed 5,175,000 units at 58 cents each, according to a news release.
In the last year, Aclarion has leveraged the expertise of spine surgeons including Roger Härtl, MD, to develop its Nociscan platform for diagnosing lower back pain. Alphatec also partnered with the company to include Nociscan with its AlphaInformatiX spine platform.